Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 1;14(9):889.
doi: 10.3390/ph14090889.

A Role of BDNF in the Depression Pathogenesis and a Potential Target as Antidepressant: The Modulator of Stress Sensitivity "Shati/Nat8l-BDNF System" in the Dorsal Striatum

Affiliations
Review

A Role of BDNF in the Depression Pathogenesis and a Potential Target as Antidepressant: The Modulator of Stress Sensitivity "Shati/Nat8l-BDNF System" in the Dorsal Striatum

Hajime Miyanishi et al. Pharmaceuticals (Basel). .

Abstract

Depression is one of the most common mental diseases, with increasing numbers of patients globally each year. In addition, approximately 30% of patients with depression are resistant to any treatment and do not show an expected response to first-line antidepressant drugs. Therefore, novel antidepressant agents and strategies are required. Although depression is triggered by post-birth stress, while some individuals show the pathology of depression, others remain resilient. The molecular mechanisms underlying stress sensitivity remain unknown. Brain-derived neurotrophic factor (BDNF) has both pro- and anti-depressant effects, dependent on brain region. Considering the strong region-specific contribution of BDNF to depression pathogenesis, the regulation of BDNF in the whole brain is not a beneficial strategy for the treatment of depression. We reviewed a novel finding of BDNF function in the dorsal striatum, which induces vulnerability to social stress, in addition to recent research progress regarding the brain regional functions of BDNF, including the prefrontal cortex, hippocampus, and nucleus accumbens. Striatal BDNF is regulated by Shati/Nat8l, an N-acetyltransferase through epigenetic regulation. Targeting of Shati/Nat8l would allow BDNF to be striatum-specifically regulated, and the striatal Shati/Nat8l-BDNF pathway could be a promising novel therapeutic agent for the treatment of depression by modulating sensitivity to stress.

Keywords: BDNF; Shati/Nat8l; depression; dorsal striatum; stress sensitivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
BDNF levels in rodent model of depression. BDNF expression in the PFC and hippocampus was decreased in the RSDS-induced depression model mice. BDNF in the PFC and hippocampus has an anti-depressant effect. BDNF expression in the NAc and dorsal striatum (dSTR) increased in a repeat social-defeat stress (RSDS)-induced depression mouse model. BDNF in the NAc and dorsal striatum shows a pro-depressant effect. Red arrows: upregulation of BDNF levels. Blue arrows: downregulation of BDNF levels.
Figure 2
Figure 2
The Shati/Nat8l-BDNF pathway in the dorsal striatum determines stress sensitivity. A model summarizing the determination of stress sensitivity by the dorsal striatal Shati/Nat8l-BDNF pathway: resilient mice do not show the upregulation of Shati/Nat8l and BDNF expression by chronic social stress; thus, vulnerability to stress is not established and subsequent stress does not induce depression-like behaviors. Susceptible mice show upregulation of Shati/Nat8l and BDNF expression by chronic social stress, resulting in the establishment of a vulnerability to stress, in which subsequent stress contributes to depression-like behaviors.

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; Arlingon, VA, USA: 2013.
    1. World Health Organization (WHO) Depression and Other Common Mental Disorders. [(accessed on 23 July 2021)]. Available online: https://www.who.int/publications/i/item/depression-global-health-estimates.
    1. Bromet E., Andrade L.H., Hwang I., A Sampson N., Alonso J., De Girolamo G., De Graaf R., Demyttenaere K., Hu C., Iwata N., et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90. doi: 10.1186/1741-7015-9-90. - DOI - PMC - PubMed
    1. Dehn L.B., Beblo T. Verstimmt, verzerrt, vergesslich: Das Zusammenwirken emotionaler und kognitiver Dysfunktionen bei Depression. Neuropsychiatrie. 2019;33:123–130. doi: 10.1007/s40211-019-0307-4. - DOI - PubMed
    1. Price R.B., Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: An integrative model. Mol. Psychiatry. 2019;25:530–543. doi: 10.1038/s41380-019-0615-x. - DOI - PMC - PubMed

LinkOut - more resources